Over the last 3 months, EPS estimates have seen 2 upward revisions and 12 downward. Revenue estimates have seen 3 upward revisions and 7 downward. Since the start of the year, 3M shares have risen 8.6 ...
Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA ...
Craig-Hallum analyst Richard Shannon maintained a Buy rating on Lumentum Holdings (LITE – Research Report) today. The company’s shares closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback